Front
Mathieu Front, Dachau DE
Patent application number | Description | Published |
---|---|---|
20120231926 | Method for Controlling a Drive Unit of a Motor Vehicle - A method is provided for controlling a drive unit of a motor vehicle with an automatic or automated transmission. The drive unit includes at least one drive motor, which generates a drive torque in an overrun mode. The drive torque acts as a drag torque or as a creep torque on the drive wheels as a function of the current speed. The level of the drive torque in the overrun mode can be at least partially controlled by actuating a brake pedal. The drag torque applied to the drive wheels in the overrun mode can be controlled by actuating the brake pedal in such a way that a reduced drag torque dependent on the actuation of the brake pedal is applied to the drive wheels. | 09-13-2012 |
Michal Front, Rudawa PL
Patent application number | Description | Published |
---|---|---|
20150065813 | SYSTEM FOR RECORDING AND PROCESSING SIGNAL FOR DIAGNOSING AUDITORY SYSTEM AND METHOD FOR RECORDING AND PROCESSING SIGNAL FOR DIAGNOSING AUDITORY SYSTEM - In system for recording and processing a signal for diagnosing an auditory system, a system for measuring signals of bioelectric activity of brain (EEG signal) or eye (EOG signal) or muscle (EMG signal) or their combination obtained from electrodes ( | 03-05-2015 |
Sophie Front, Saint-Denis-En-Val FR
Patent application number | Description | Published |
---|---|---|
20110224162 | SYNTHETIC ANALOGUES OF PHOSPHATIDYL-MYO-INOSITOL MANNOSIDES WITH AN INHIBITORY ACTIVITY OF THE INFLAMMATORY RESPONSE - The present invention relates to novel synthetic analogues of phosphatidyl-myo-inositol mannosides (hereinafter referred to as PIMs) of general formula (I): or a pharmaceutically acceptable salt thereof, to the method for preparing same and to the use thereof in the prevention or treatment of a disease associated with the overexpression of cytokines or of chemokines, in particular of TNF and/or of IL-12. The invention also relates to a pharmaceutical composition comprising at least one synthetic derivative of PIM. | 09-15-2011 |